When Novartis announced it was teaming up with the NFL last month, the company called it the first-ever corporate pharmaceutical partnership with the league. But it wasn’t exactly the only matchup ...

Pharma advertisers have kicked off 2025 with a bang, with the top 10 spenders throwing almost 30% more money behind their TV ...

Real Chemistry, a 2024 MM+M Agency 100 honoree, appointed Cali Howitt, PhD, as president of U.S. medical and executive leader for its promotional and medical affairs business in the U.S. General ...

It binds both transmembrane and soluble TREM2, triggering a rise in CSF sTREM2. Single and multi-dose studies of the small ...

Droplet digital PCR measurements of circulating tumor (ct)DNA to assess minimal residual disease before the initiation of ...

When it comes to Big Pharma, the likes of Novartis, Bristol Myers Squibb and AstraZeneca have Bluesky accounts — though none ...

Droplet digital polymerase chain reaction (PCR) measurements of cell-free, circulating tumor DNA (ctDNA) can identify ...

Entrepreneurial CMO 50 list recognizes fifty chief marketers whose approach to driving growth is charting new paths.

Regulators in the US and Europe have started to review Novartis' biosimilar version of ... and Crohn's disease in the US, ad highly-active RRMS in the EU. The looming competition piles further ...

Researchers showed that approximately 80 percent of stage 3 melanoma patients who had detectable levels of circulating tumor ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...